NCT04582032View on ClinicalTrials.gov

Effects of Cyclooxygenase (COX) 1-2 Inhibitors on Prevention of Rocuronium Injection Pain

NACompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

November 1, 2020

Primary Completion Date

December 4, 2020

Study Completion Date

January 4, 2021

Conditions
Injection Site Irritation
Interventions
DRUG

Dexketoprofen (KETAVEL 50 mg/2 ml)

intravenous dexketoprofen (KETAVEL 50 mg/2 ml)

DRUG

Saline (Isotonic Saline Solution 0.9% )

intravenous 2 ml of saline

Trial Locations (1)

Unknown

Kecioren Training and Research Hospital, Ankara

All Listed Sponsors
lead

Ankara City Hospital Bilkent

OTHER

NCT04582032 - Effects of Cyclooxygenase (COX) 1-2 Inhibitors on Prevention of Rocuronium Injection Pain | Biotech Hunter | Biotech Hunter